Hong-Kyun Park, Jong-Ho Park, Hee-Kwon Park, Kyusik Kang, Keun-Hwa Jung, Beom Joon Kim, Jin-Man Jung, Young Seo Kim, Yong-Seok Lee, Hyo Suk Nam, Yeonju Yu, Juneyoung Lee, Keun-Sik Hong
{"title":"从他汀类药物单药治疗转向瑞舒伐他汀加依折替贝实现ldl -胆固醇目标:一项多中心、开放标签、单组试验","authors":"Hong-Kyun Park, Jong-Ho Park, Hee-Kwon Park, Kyusik Kang, Keun-Hwa Jung, Beom Joon Kim, Jin-Man Jung, Young Seo Kim, Yong-Seok Lee, Hyo Suk Nam, Yeonju Yu, Juneyoung Lee, Keun-Sik Hong","doi":"10.5853/jos.2024.05015","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17135,"journal":{"name":"Journal of Stroke","volume":"27 2","pages":"275-278"},"PeriodicalIF":6.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152452/pdf/","citationCount":"0","resultStr":"{\"title\":\"Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial.\",\"authors\":\"Hong-Kyun Park, Jong-Ho Park, Hee-Kwon Park, Kyusik Kang, Keun-Hwa Jung, Beom Joon Kim, Jin-Man Jung, Young Seo Kim, Yong-Seok Lee, Hyo Suk Nam, Yeonju Yu, Juneyoung Lee, Keun-Sik Hong\",\"doi\":\"10.5853/jos.2024.05015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17135,\"journal\":{\"name\":\"Journal of Stroke\",\"volume\":\"27 2\",\"pages\":\"275-278\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152452/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Stroke\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5853/jos.2024.05015\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5853/jos.2024.05015","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/31 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Journal of StrokeCLINICAL NEUROLOGYPERIPHERAL VASCULAR DISE-PERIPHERAL VASCULAR DISEASE
CiteScore
11.00
自引率
3.70%
发文量
52
审稿时长
12 weeks
期刊介绍:
The Journal of Stroke (JoS) is a peer-reviewed publication that focuses on clinical and basic investigation of cerebral circulation and associated diseases in stroke-related fields. Its aim is to enhance patient management, education, clinical or experimental research, and professionalism. The journal covers various areas of stroke research, including pathophysiology, risk factors, symptomatology, imaging, treatment, and rehabilitation. Basic science research is included when it provides clinically relevant information. The JoS is particularly interested in studies that highlight characteristics of stroke in the Asian population, as they are underrepresented in the literature.
The JoS had an impact factor of 8.2 in 2022 and aims to provide high-quality research papers to readers while maintaining a strong reputation. It is published three times a year, on the last day of January, May, and September. The online version of the journal is considered the main version as it includes all available content. Supplementary issues are occasionally published.
The journal is indexed in various databases, including SCI(E), Pubmed, PubMed Central, Scopus, KoreaMed, Komci, Synapse, Science Central, Google Scholar, and DOI/Crossref. It is also the official journal of the Korean Stroke Society since 1999, with the abbreviated title J Stroke.